CANCER THERAPY-RELATED CARDIOVASCULAR TOXICITY

Clinical trials for CANCER THERAPY-RELATED CARDIOVASCULAR TOXICITY explained in plain language.

Never miss a new study

Get alerted when new CANCER THERAPY-RELATED CARDIOVASCULAR TOXICITY trials appear

Sign up with your email to follow new studies for CANCER THERAPY-RELATED CARDIOVASCULAR TOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New study seeks to catch hidden heart damage in young cancer survivors

Diagnosis Not yet recruiting

This study aims to improve early detection of heart problems in children and young adults who survived cancer treatment. Researchers will test 100 participants aged 2-25 using advanced heart scans, exercise tests, and blood markers to find better ways to spot hidden heart damage.…

Matched conditions: CANCER THERAPY-RELATED CARDIOVASCULAR TOXICITY

Phase: NA • Sponsor: Centre Hospitalier Universitaire de Liege • Aim: Diagnosis

Last updated Mar 23, 2026 15:17 UTC

CANCER THERAPY-RELATED CARDIOVASCULAR TOXICITY

Get alerted when new CANCER THERAPY-RELATED CARDIOVASCULAR TOXICITY trials appear

New study seeks to catch hidden heart damage in young cancer survivors